Back to Search
DOMINIC CASTELLANO, MD
MD
Otolaryngology/Facial Plastic Surgery Physician
NPI: 1962688317IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
Otolaryngology/Facial Plastic Surgery PhysicianPrimary
Otolaryngology — Otolaryngology/Facial Plastic Surgery
Code: 207YX0905X
ME101498(FL)
Education
UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Class of 2002
Research & Publications (20)
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
PMID 19615940·Lancet Oncol·2009
3-trial
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population.
PMID 19549706·Ann Oncol·2009
3-trial
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer.
PMID 19259675·Cancer Chemother Pharmacol·2009
6-review
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
PMID 17169762·Clin Transl Oncol·2006
2-rct
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
PMID 17156477·BMC Cancer·2006
3-trial
Structure-activity relationship (SAR) studies of benzoxazinones, their degradation products, and analogues. Phytotoxicity on problematic weeds Avena fatua L. and Lolium rigidum Gaud.
PMID 16478215·J Agric Food Chem·2006
8-other
Stridor and dysphagia in diffuse idiopathic skeletal hyperostosis (DISH).
PMID 16467731·Laryngoscope·2006
5-case
Application of Hansch's model to guaianolide ester derivatives: a quantitative structure-activity relationship study.
PMID 15853398·J Agric Food Chem·2005
8-other
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
PMID 15701857·Clin Cancer Res·2005
3-trial
Degradation studies on benzoxazinoids. Soil degradation dynamics of (2R)-2-O-beta-D-glucopyranosyl-4-hydroxy-(2H)- 1,4-benzoxazin-3(4H)-one (DIBOA-Glc) and its degradation products, phytotoxic allelochemicals from Gramineae.
PMID 15686401·J Agric Food Chem·2005
8-other
Structure-Activity Relationships (SAR) studies of benzoxazinones, their degradation products and analogues. phytotoxicity on standard target species (STS).
PMID 15686399·J Agric Food Chem·2005
8-other
Degradation studies on benzoxazinoids. Soil degradation dynamics of 2,4-dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one (DIMBOA) and its degradation products, phytotoxic allelochemicals from gramineae.
PMID 15478999·J Agric Food Chem·2004
8-other
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
PMID 15305408·Cancer·2004
3-trial
Unusual response to gemcitabine in a case of peritoneal malignant fibrous histiocytoma.
PMID 14501390·Anticancer Drugs·2003
5-case
Radiation recall dermatitis induced by pegylated liposomal doxorubicin.
PMID 12960743·Anticancer Drugs·2003
5-case
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.
PMID 12702534·Ann Oncol·2003
3-trial
Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial.
PMID 12377658·Ann Oncol·2002
3-trial
Sesquiterpene lactones with potential use as natural herbicide models. 2. guaianolides.
PMID 11087474·J Agric Food Chem·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- FLORIDA ENT & ALLERGY, 13015 SUMMERFIELD SQUARE DR
RIVERVIEW, FL 33578 - Phone
- (813) 879-8045
Quick Facts
- NPI
- 1962688317
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile